References
- 1. Bellini M, Tonarelli S, Nagy AG, Pancetti A, Costa F, Ricchiuti A, Bortoli N, Mosca M, Marchi S, Rossi A. Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients 2020 Jan; 12(1): 148.
- 2. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 2010 Feb; 25(2): 252–258.
- 3. Mansueto P, Seidita A, D’Alcamo A, Carroccio A. Role of FODMAPs in Patients with Irritable Bowel Syndrome. Nutr Clin Pract 2015 Oct; 30(5): 665–682.
- 4. Zanetti AJA, Rogero MM, von Atzingen MCBC. Low-FODMAP diet in the management of irritable bowel syndrome. Nutrire 2018; 43: 17.
- 5. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006 Oct; 106(10): 1631–1639.
- 6. Charlebois A, Rosenfeld G, Bressler B. The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review. Crit Rev Food Sci Nutr 2016 Jun 10; 56(8): 1370–1378.
- 7. University of Virginia, UVA Nutrition [Internet]. Available from: https://med.virginia.edu/ginutrition/wp-content/uploads/sites/199/2018/05/Low_FODMAP_Diet_12.16.pdf [cited 23 March 2022].
- 8. Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV. Gastroenterology 2016 Feb 19; S0016-5085(16)00223-7.
- 9. Zahedi MJ, Behrouz V, Azimi M. Low fermentable oligo-di-monosaccha-rides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial. J Gastroenterol Hepatol 2018 Jun; 33(6): 1192–1199.
- 10. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FOD-MAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014 Jan; 146(1): 67–75.e5.
- 11. Schumann D, Klose P, Lauche R, Dobos G, Langhorst J, Cramer H. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Nutrition 2018 Jan; 45: 24–31.
- 12. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16(24): 2978–2990.
- 13. Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SS. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth. Aliment Pharmacol Ther 2013 Jun; 37(11): 1103–1111.
- 14. Rao SSC, Bhagatwala J. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management. Clin Transl Gastroenterol 2019 Oct; 10(10): e00078.
- 15. Achufusi TGO, Sharma A, Zamora EA, Manocha D. Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods. Cureus 2020 Jun 27; 12(6): e8860.
- 16. Borghini R, Donato G, Alvaro D, Picarelli A. New insights in IBS-like disorders: Pandora’s box has been opened; a review. Gastroenterol Hepatol Bed Bench 2017 Spring; 10(2): 79–89. PMID: 28702130; PMCID: PMC5495893.
- 17. Guilliams TG, Drake LE. Small Intestinal Bacterial Overgrowth (SIBO): Diagnostic Challenges and Functional Solutions; 2021.
- 18. Mills SC, von Roon AC, Tekkis PP, Orchard TR. Crohn’s disease. BMJ Clin Evid 2011; 0416. Published 2011 Apr 27.
- 19. Chiba M, Abe T, Tsuda H, Sugawara T, Tsuda S, Tozawa H, Fujiwara K, Imai H. Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet. World J Gastroenterol 2010; 16: 2484–2495.
- 20. Truswell AS, Seach JM, Thorburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr 1988; 48: 1424–1430.
- 21. Parker K, Salas M, Nwosu VC. High fructose corn syrup: Production, uses and public health concerns. Biotechnol Mol Biol Rev 2010; 5: 71–78.
- 22. Rumessen JJ, Gudmand-Høyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986; 27: 1161–1168.
- 23. van den Bogert B, de Vos WM, Zoetendal EG, Kleerebezem M. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol 2011; 77: 2071–2080.
- 24. Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm. Bowel Dis 2016; 22: 1129–1136.
- 25. Kakodkar S, Farooqui, AJ, Mikolaitis SL, Mutlu EA. The Specific Carbohydrate Diet for Inflammatory Bowel Disease: A Case Series. J Acad Nutr Diet 2015; 115: 1226–1232.
- 26. Barbalho SM, Goulart RA, Aranão ALC, de Oliveira PGC. Inflammatory Bowel Diseases and Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols: An Overview. J Med Food 2018 Jul; 21(7): 633– 640. https://doi.org/10.1089/jmf.2017.0120. Epub 2018 Jan 12. PMID: 29328869.
- 27. Barrett JS, Gibson PR. Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index. J Am Diet Assoc 2010; 110: 1469–1476.
- 28. Gibson PR. Use of the low-FODMAP diet in inflammatory bowel disease. J Gastroenterol Hepatol 2017; 32 Suppl 1: 40–42.
- 29. Schwender B, Floch MH. Should FODMAP withdrawal be tried in inflammatory bowel disease patients with irritable bowel syndrome? J Clin Gastroenterol 2014; 48: 393–394.
- 30. Popa SL, Pop C, Dumitrascu DL. Diet Advice for Crohn’s Disease: FODMAP and Beyond. Nutrients 2020 Dec 6; 12(12): 3751.
- 31. Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, Ibraim SB, Roume H, Levenez F, Pons N, Maziers N, Lomer MC, Ehrlich SD, Irving PM, Whelan K. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients with Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology 2020 Jan; 158(1): 176–188.e7.
- 32. Melgaard D, Sørensen J, Riis J, Ovesen TS, Leutscher P, Sørensen S, Knudsen JK, Bundgaard-Nielsen C, Ejstrup J, Jensen AM, Borre M, Krarup AL. Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome: A Feasibility Study. Nutrients 2022 Mar 18; 14(6): 1296.
- 33. Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. J Crohns Colitis 2017 Dec 4; 11(12): 1420–1429.
- 34. Kristianslund CH, Hatlebakk JG, Hausken T, Morken MH, Kahrs GE. PP083-SUN: Effect of Fodmap-Restricted DIET on Gastroesophageal Reflux Disease. Clinical Nutrition; 33: S50. Sep 2014. https://doi.org/10.1016/S0261-5614(14)50125-2.
- 35. Rivière P, Vauquelin B, Rolland E, Melchior C, Roman S, Bruley des Varannes S, Mion F, Gourcerol G, Sacher-Huvelin S, Zerbib F. Low FODMAPs diet or usual dietary advice for the treatment of refractory gastroesophageal reflux disease: An open-labeled randomized trial. Neurogastroenterol Motil 2021 Sep; 33(9): e14181.
- 36. Patcharatrakul T, Linlawan S, Plaidum S, Gonlachanvit S. The Effect of Rice vs. Wheat Ingestion on Postprandial Gastroesophageal Reflux (GER) Symptoms in Patients with Overlapping GERD-Irritable Bowel Syndrome (IBS). Foods 2021 Dec 23; 11(1): 26.
- 37. Staudacher HM. Nutritional, microbiological and psychosocial implications of the low FODMAP diet. J Gastroenterol Hepatol 2017 Mar; 32 Suppl 1: 16–19. https://doi.org/10.1111/jgh.13688. PMID: 28244658.
- 38. Catassi G, Lionetti E, Gatti S, Catassi C. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients 2017 Mar 16; 9(3): 292. https://doi.org/10.3390/nu9030292. PMID: 28300773; PMCID: PMC5372955.
- 39. Hill P, Muir JG, Gibson PR. Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y) 2017 Jan; 13(1): 36–45. PMID: 28420945; PMCID: PMC5390324.